Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.82 per Ordinary share on 8 January 2009 through the Company's ShareReward Plan ("the Plan") which the under-mentioned persons entered on 5 October 2001:
Mr A P Witty |
Acquisition of 20 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr J S Heslop |
Acquisition of 20 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr S M Bicknell |
Acquisition of 20 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr E J Gray |
Acquisition of 20 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr D Learmouth |
Acquisition of 20 Ordinary shares under the Dividend Reinvestment element of the Plan |
Dr D Pulman |
Acquisition of 8 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr D S Redfern |
Acquisition of 20 Ordinary shares under the Dividend Reinvestment element of the Plan |
Ms C Thomas |
Acquisition of 20 Ordinary shares under the Dividend Reinvestment element of the Plan |
The Company and the above-mentioned persons were advised of this information on 9 January 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
9 January 2009